Acrivon Competitors and Similar CompaniesClear all

Iksuda Therapeutics's competitors and similar companies include CARsgen Therapeutics, Numab and OncoTherapy Science.
Iksuda Therapeutics
Iksuda Therapeutics
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
CARsgen Therapeutics
CARsgen Therapeutics
CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.
Numab
Numab
Numab Therapeutics is an oncology-focused biopharmaceutical company.
OncoTherapy Science
OncoTherapy Science
OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
Founding Date
Founding Date
2007
Founding Date
2014
Founding Date
2011
Founding Date
2001
Type
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Newcastle upon Tyne, GB HQ
Newton, US
Locations
Shanghai, CN HQ
Beijing, CN
Shanghai, CN
Shanghai, CN
Bellaire, US
Locations
Wädenswil, CH HQ
Locations
Kawasaki, JP HQ
Employees
Employees
43
Employees
100
Employees
681% decrease
Employees
54

Funding

Latest funding round
Latest funding round
$ 47m (about 5 years ago)
Latest funding round
$ 186m (over 5 years ago)
Latest funding round
$ 110m (about 5 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 47m
Total funding raised
$ 276m
Total funding raised
$ 132.3m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

CARsgen Therapeutics
HQ
Shanghai, CN
Employees
100

CARsgen Therapeutics is a clinical-stage immune-oncology company that develops a new chimeric T-cell antigen receptor for liver, lung, stomach and brain cancers treatment.

View company
Numab
HQ
Wädenswil, CH
Employees
68↓ 1% decrease

Numab Therapeutics is an oncology-focused biopharmaceutical company.

View company
OncoTherapy Science
HQ
Kawasaki, JP
Employees
54

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.

View company